Digilib Perpustakaan Universitas Riau

Tugas Akhir, Skripsi, Tesis dan Disertasi Mahasiswa Universitas Riau

  • Beranda
  • Informasi
  • Berita
  • Bantuan
  • Pustakawan
  • Pilih Bahasa :
    Bahasa Arab Bahasa Bengal Bahasa Brazil Portugis Bahasa Inggris Bahasa Spanyol Bahasa Jerman Bahasa Indonesia Bahasa Jepang Bahasa Melayu Bahasa Persia Bahasa Rusia Bahasa Thailand Bahasa Turki Bahasa Urdu

Pencarian berdasarkan :

SEMUA Pengarang Subjek ISBN/ISSN Pencarian Spesifik

Pencarian terakhir:

{{tmpObj[k].text}}
Image of Profil Dan Tingkat Keberlangsungan Hidup Pasien Kanker Prostat Di Rsud Arifin Achmad Provinsi Riau Tahun 2016-2018
Penanda Bagikan

CD Skripsi

Profil Dan Tingkat Keberlangsungan Hidup Pasien Kanker Prostat Di Rsud Arifin Achmad Provinsi Riau Tahun 2016-2018

Rifqoh Awina Utami / 2008134838 - Nama Orang;

Prostate cancer is a malignancy that originates from the epithelium of the prostate gland. It is a disease characterized by the uncontrolled growth of cells in the prostate gland. The primary objective of this study was to determine the profile and survival rate of prostate cancer patients at Arifin Achmad Hospital Pekanbaru in the 2016-2018 period. This was a retrospective descriptive study with univariate analysis done on August-December 2023 in the Medical Records Installation of Arifin Achmad Hospital, Riau Province. The data were collected from observation of the diagnosis results in the patient's medical record. The data obtained were treated and presented in frequency distribution table. The research results showed that the highest percentage of patients diagnosed with prostate cancer came from the 60-74 year age group, there is 19 (73.1%) patients. In digital rectal examination, the majority of patients who received negative results were 22 (84.6%) patients. Based on supporting examinations, the majority of prostate cancer patients underwent anatomical histopathological examination were 21 (80.8%) patients, patients who obtained results > 4 ng/mL on PSA examination were 22 (84.6%) patients. The most cancer stages were in Gleason score grade group V were 8 (30.8%) patients. Only 6 (23.1%) patients had metastases to other organs. No patients underwent TRUS examination, and only 2 (7.7%) patients underwent MRI examination. The majority of prostate cancer patients underwent treatment using ADT, there is 19 (73.1%) patients. The 5 year survival rate for prostate cancer patients were 15 (57.7%) patients.



Keywords : Prostate Cancer, PSA, Gleason Score, 5 Year Survival Rate


Ketersediaan
#
Perpustakaan Universitas Riau 2008134838
2008134838
Tersedia
Informasi Detail
Judul Seri
-
No. Panggil
2008134838
Penerbit
Pekanbaru : Universitas Riau – FKEDOKTERAN - Kedokteran., 2024
Deskripsi Fisik
-
Bahasa
Indonesia
ISBN/ISSN
-
Klasifikasi
2008134838
Tipe Isi
-
Tipe Media
-
Tipe Pembawa
-
Edisi
-
Subjek
KEDOKTERAN
Info Detail Spesifik
-
Pernyataan Tanggungjawab
Mutia
Versi lain/terkait

Tidak tersedia versi lain

Lampiran Berkas
  • COVER
  • ABSTRAK
  • DAFTAR ISI
  • BAB I PENDAHULUAN
  • BAB II TINJAUAN PUSTAKA
  • BAB III METODE PENELITIAN
  • BAB IV HASIL PENELITIAN
  • BAB V PEMBAHASAN
  • BAB VI SIMPULAN DAN SARAN
  • DAFTAR PUSTAKA
  • LAMPIRAN
Komentar

Anda harus masuk sebelum memberikan komentar

Digilib Perpustakaan Universitas Riau
  • Informasi
  • Layanan
  • Pustakawan
  • Area Anggota

Tentang Kami

As a complete Library Management System, SLiMS (Senayan Library Management System) has many features that will help libraries and librarians to do their job easily and quickly. Follow this link to show some features provided by SLiMS.

Cari

masukkan satu atau lebih kata kunci dari judul, pengarang, atau subjek

Donasi untuk SLiMS Kontribusi untuk SLiMS?

© 2025 — Senayan Developer Community

Ditenagai oleh SLiMS
Pilih subjek yang menarik bagi Anda
  • Karya Umum
  • Filsafat
  • Agama
  • Ilmu-ilmu Sosial
  • Bahasa
  • Ilmu-ilmu Murni
  • Ilmu-ilmu Terapan
  • Kesenian, Hiburan, dan Olahraga
  • Kesusastraan
  • Geografi dan Sejarah
Icons made by Freepik from www.flaticon.com
Pencarian Spesifik
Kemana ingin Anda bagikan?